The in vitro activities of the new spectinomycin analog U-63366, the new macrolide roxithromycin (RU 28965), and five new quinolone derivatives (pefloxacin, rosoxacin, norfloxacin, ofloxacin, and ciprofloxacin) were studied against 23 multiresistant strains of Haemophilus ducreyi (beta-lactamase producers) isolated in Paris and were compared with the activities of tetracycline, minocycline, chloramphenicol, streptomycin, kanamycin, gentamicin, spectinomycin, erythromycin, and nalidixic acid. All strains were uniformly susceptible to the seven new antibiotics tested. Ciprofloxacin had the greatest inhibitory effect in vitro (the MIC for 90% of the strains tested [MIC90] was 0.016 ,ug/ml), and U-63366 was the most active aminoglycosideaminocyclitol antibiotic (MIC90, 0.25 ,ug/ml).
Chancroid is a sexually transmitted disease caused by Haemophiliis ducreyi. Most of the current clinical isolates produce a beta-lactamase (2, 4) , and many of them are resistant to sulfonamides (5, 15) , tetracycline (1, 5, 12) , and chloramphenicol (11, 15) , while some are also resistant to aminoglycoside antibiotics (9, 10, 14, 15) and to trimethoprim (2, 15) . The in vitro resistance of H. duicreyi has been correlated with treatment failure (5) , and a high rate of clinical failures of treatment with trimethoprim-sulfamethoxazole has recently been reported in Thailand (16) . Yet this combination had been advocated as the treatment of choice for chancroid. In light of the decreasing number of useful antibiotics, it seemed reasonable to study the possible utility of U-63366, a new spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five new quinolone derivatives for the treatment of chancroid. We therefore tested the in vitro susceptibility to these new antibiotics of 23 multiresistant strains isolated in Paris.
(This study was presented in part at the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1985, Minneapolis, Minn., abstr. no. 402 .)
The following antimicrobial agents, supplied by their respective manufacturers, were tested: tetracycline hydrochloride (Rhone-Poulenc); minocycline (Lederle); chloramphenicol, erythromycin, roxithromycin, and ofloxacin (Roussel Uclaf); streptomycin (Specia); spectinomycin and U-63366 (6'-propyl spectinomycin pentahydrate sulfate) (Upjohn); kanamycin (Bristol); gentamicin (Unilabo); nalidixic acid and rosoxacin (Winthrop); pefloxacin (Roger Bellon); norfloxacin (Merck-Sharp and Dohme); and ciprofloxacin (Bayer Pharma). The 23 strains of H. ducreyi isolated in Paris were chosen because of their multiresistance characters. They were all resistant to tetracycline (Tcr) and ampicillin (Apr), and all produced a beta-lactamase as determined with the rapid chromogenic cephalosporin test (7); 13 strains were also resistant to chloramphenicol (Cmr) and showed a chloramphenicol acetyltransferase activity that was assayed as previously described (11); three of these strains were moreover resistant to streptomycin (Smr) and * Corresponding author. kanamycin (Kmr) and produced a streptomycin phosphotransferase and a 3',5"-aminoglycoside phosphotransferase of type I (10). Thus, the distribution of resistance phenotypes was 10 Apr Tcr, 10 Apr Tcr Cmr, and 3 Apr Tcr Cmr Smr Kmr. MICs were determined as previously described (12) (17) .
In tropical areas, chancroid is a major cause of genital ulceration, but it may also be a clinical problem in temperate climates. A significant proportion of the H. ducreyi isolates have been shown to be resistant to one or more of the antimicrobial agents recommended for therapy (2, 4, 5, 12) . This resistance is commonly plasmid mediated (6, 10). The MICs of roxithromycin for H. ducreyi are similar to those of erythromycin, which is one of the few drugs for the treatment of chancroid that has been proven to be effective worldwide (8) (3) .
On the basis of their in vitro efficacy and of pharmacological data, these new drugs might be useful agents for the treatment of chancroid. Further studies and clinical trials clearly are warranted.
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